Status | Study |
Recruiting |
Study Name: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Condition: Germ Cell Tumor Nonseminomatous Germ Cell Tumor Date: 2017-05-16 Interventions: Drug: Durvalumab 1500 mg by IV |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: Retroperitoneal Lymph Node Dissection in Treating Patients With Stage I-IIA Testicular Seminoma Condition: Lymphadenopathy Stage I Testicular Seminoma Date: 2015-08-29 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Germ Cell Tumor Teratoma Choriocarcinoma Date: 2015-02-20 Interventions: Drug: paclitaxel IV |
Recruiting |
Study Name: Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer Condition: Testicular Neoplasms Seminoma Date: 2015-01-14 Interventions: Drug: Bleomycin Etoposide and Cisplatin |
Recruiting |
Study Name: Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma Condition: Seminoma Date: 2013-06-24 Interventions: Drug: Carboplatin |
Terminated |
Study Name: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors Condition: Adult Central Nervous System Germ Cell Tumor Adult Teratoma Date: 2013-03-06 Interventions: Drug: palifosfamide Given IV Other Names: |
Recruiting |
Study Name: A Multi-Centre Phase II Study Using Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT Condition: Metastatic Seminoma Date: 2012-11-06 Interventions: Drug: Carboplatin AUC-10 Carboplatin will be administered |
Recruiting |
Study Name: Therapy De-escalation in Seminoma Stage IIA/B Condition: Seminoma Date: 2012-05-01 Interventions: Drug: Carboplatin Stage IIA: 1 |
Active, not recruiting |
Study Name: Proton Radiotherapy for Stage I, IIA, and IIB Seminoma Condition: Stage I, IIA and IIB Seminoma Date: 2012-03-16 Interventions: Radiation: Proton Radiation Therapy |